cardiovascular · Mechanism Report
Is the LPA rs10455872 G allele linked to higher lipoprotein(a) and coronary heart disease risk?
The LPA rs10455872 G allele is associated with higher lipoprotein(a) levels and increased coronary heart disease risk.
This is what AI claimed
The LPA rs10455872 G allele is associated with genetically higher lifelong lipoprotein(a) levels and increased coronary heart disease risk.
Executive summary
The G allele is linked to higher lifelong lipoprotein(a) levels and smaller apolipoprotein(a) isoforms, both associated with coronary heart disease. It indicates inherited susceptibility rather than determining an individual's absolute risk.
Verified conclusion
The LPA rs10455872 G allele is a well-established genetic marker of elevated lipoprotein(a) [Lp(a)] and higher coronary heart disease risk. For a 71-year-old man, this genotype would indicate inherited susceptibility rather than determine his personal absolute risk, which also depends on measured Lp(a), established cardiovascular disease, and other clinical risk factors.
Clinical and genetic evidence
- rs10455872 shows a clear allele-dose association with Lp(a). In EPIC-Norfolk, median Lp(a) was 9.7 mg/dL for AA, 45.1 mg/dL for AG, and 69.8 mg/dL for GG genotypes, measured with an apo(a)-isoform-independent assay.
- Large predominantly European-ancestry studies estimate roughly a 30 mg/dL Lp(a) increase per G allele; this variant explains approximately 20–30% of Lp(a) variation in those populations.
- Coronary heart disease risk is also higher: meta-analytic evidence estimates an odds ratio of 1.47 per G allele (95% CI 1.35–1.60). An early case-control estimate was OR 1.70 (95% CI 1.49–1.95).
Mechanistic interpretation
- The G allele is associated with smaller apolipoprotein(a) [apo(a)] isoforms, a phenotype independently associated with coronary disease in Mendelian-randomization analysis.
- rs10455872 may tag linked LPA KIV-2 copy-number variation and apo(a)-isoform architecture rather than directly alter apo(a) synthesis.
- In PROCARDIS, adjustment for measured Lp(a) attenuated the association of an LPA genotype score with coronary disease to OR 1.02 (95% CI 0.88–1.18), supporting Lp(a) as a principal pathway, while not proving complete mediation.
Clinical implications
- Effects and allele frequency are best characterized in European-ancestry populations; exact Lp(a) levels and risk effects vary by ancestry and assay.
Bottom line
- rs10455872 G carriage is convincingly associated with genetically elevated Lp(a), smaller apo(a) isoforms, and increased coronary heart disease risk; measured Lp(a) is the clinically relevant phenotype for interpreting this inherited risk.
References
- Lipoprotein(a) Levels, Genotype, and Incident Aortic Valve Stenosis — ahajournals.org
- Genetics and Pathophysiological Mechanisms of Lipoprotein(a)‐Associated Cardiovascular Risk | Journal of the American Heart Association — ahajournals.org
- Using topic modeling via non-negative matrix factorization to identify relationships between genetic variants and disease phenotypes: A case study of Lipoprotein(a) (LPA) — journals.plos.org
- The rs10455872-G allele of the LPA gene is associated with high ... — pmc.ncbi.nlm.nih.gov
- Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary ... — nejm.org
- Genetic Variants in the Apolipoprotein(a) Gene and Coronary Heart Disease | Circulation: Cardiovascular Genetics — ahajournals.org
- Genetics and Pathophysiological Mechanisms of Lipoprotein(a)‐Associated Cardiovascular Risk | Journal of the American Heart Association — ahajournals.org
- Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis — thelancet.com
See a full patient report verified like this
Book a walkthrough